An intrauterine pressure catheter (IUPC) is a device placed inside a pregnant woman’s uterus to monitor uterine contractions during labor. During labor, a woman’s uterus contracts to dilate, or open, the cervix and push the fetus into the birth canal. The catheter measures the pressure within the amniotic space during contractions and allows physicians to evaluate the strength, frequency, and duration of contractions. Those measurements enable physicians to evaluate the progression of labor and intervene when contractions are too weak to properly dilate a laboring woman’s cervix to successfully deliver a fetus. Though IUPCs are not used routinely, they are important in cases where external fetal monitoring is not sufficient to monitor a difficult labor. Intrauterine pressure catheters give physicians an extremely accurate measurement of intrauterine pressure, making it possible to determine whether intervention is needed to progress the labor.

Mary Ware Dennett, an activist in the US for birth control and sex education in the early twentieth century, wrote an educational pamphlet in 1915 called “The Sex Side of Life, and it was published in 1919. The pamphlet defined the functions of the sex organs, emphasized the role of love and pleasure in sex, and described other sexual processes of the body not usually discussed openly. In the early twentieth century in the US, individuals did not have wide access to sex education due to the limitations enforced by the Comstock Act, which prohibited the distribution and discussion of topics that were considered obscene. In 1929, the US tried Dennett for mailing her pamphlet as a violation of the Comstock Act, sending obscene material through the United States Postal Service. Dennett’s pamphlet, Tthe “Sex Side of Life,” and her subsequent trial, United States v. Dennett, contributed to a national discussion about sex education and human reproduction and led to the revision of reproduction- related obscenity laws.

Boris Ephrussi and George Wells Beadle developed a transplantation technique on flies, Drosophila melanogaster, which they described in their 1936 article A Technique of Transplantation for Drosophila. The technique of injecting a tissue from one fly larva into another fly larva, using a micropipette, to grow that tissue in the second larvae, was a means for investigating development of Drosophila. Through this technique, Beadle and Ephrussi studied the role of genes in embryological processes. Beadle and Ephrussi were the first to apply the transplantation method, which had previously been used in the study of larger insects, to the smaller sized Drosophila. Beadle and Ephrussi used this method of transplantation to determine if parts of the optic disc, the section of a larvae that later become the eye buds in the adult, could be extracted from one larva and transplanted into another. They later built upon this research to relate the production of molecules in cells to gene function.

The Pfeffer Zelle (Pfeffer Cell Apparatus), invented by Wilhelm Pfeffer in 1877, measured the minimum pressure needed to prevent a pure solvent from passing into a solution across a semi-permeable membrane, called osmotic pressure. The apparatus provided Pfeffer with a way to quantitatively measure osmotic pressure. Pfeffer devised the apparatus in the 1870s at the University of Basel in Basel, Switzerland, and he described the Pfeffer Cell Apparatus in his 1877 book Osmotische Untersuchungen: Studien Zur Zellmechanik (Osmotic Investigations: Studies on Cell Mechanics). Pfeffer relied on nineteenth century experiments of Moritz Traube in Germany, who constructed artificial copper ferrocyanide membranes to study osmosis. The apparatus enabled Pfeffer to study osmosis and osmotic pressure as plants grow, and later researchers used it to explain how plants develop.

The Dalkon Shield was an intrauterine contraceptive device (IUD) that women used in the early 1970s and 1980s. Produced by the A.H. Robins Company in the US, the Dalkon Shield was a contraceptive device placed directly into a woman’s uterus that was supposed to prevent the development of a fetus in the uterus. In the 1980s, researchers uncovered an array of severe birth defects and injuries caused by the Dalkon shield, including pelvic infection, infertility, and death of the user. Eventually the A.H. Robins Company took the shield off the market, and the US Food and Drug Administration banned the device. Some users of the Dalkon shield sued the producers of the device, winning millions of dollars in compensation and punitive damages. After the dangers of the Dalkon Shield became public through those lawsuits, the popularity of intrauterine devices decreased significantly in the US.

The Whelan Method of Sex Selection is a method for increasing a couple’s probability of conceiving an infant of the desired sex through timing intercourse. Elizabeth Whelan, a public health researcher, suggested that couples only have intercourse at specific times during the woman’s menstrual cycle based on whether they wanted a female or male infant. Whelan published her method in her book, Boy or Girl, in 1977. During the mid-to-late twentieth century, researchers offered other methods of timing intercourse for sex selection, but their results were based on studies of artificial insemination, rather than naturally occurring pregnancies. Whelan claimed her method was supported by natural insemination studies and that it worked for couples trying to conceive an infant of a particular sex.

Physician researchers Edgar Rey Sanabria and Héctor Martínez-Gómez developed the Kangaroo Mother Program in Bogotá, Colombia, in 1979, as an alternative to conventional incubator treatment for low birth weight infants. As of 2018, low birth weight and its associated complications are the leading causes of infant death, especially in developing and underdeveloped countries where access to technology and skilled healthcare providers is limited. Kangaroo Mother Care is a simple and low cost method for treating low birth weight infants. Even though researchers developed Kangaroo Mother Care for infants born in hospitals with limited resources, they demonstrated that the method could be just as effective as conventional treatments. Kangaroo Mother Care changed the standard of care for low birth weight infants, making life-saving medical treatments accessible to thousands of infants in developing and undeveloped countries.

Matthew Meselson, Franklin Stahl, and Jerome Vinograd, developed cesium chloride, or CsCl, density gradient centrifugation in the 1950s at the California Institute of Technology, or Caltech, in Pasadena, California. Density gradient centrifugation enables scientists to separate substances based on size, shape, and density. Meselson and Stahl invented a specific type of density gradient centrifugation, called isopycnic centrifugation that used a solution of cesium chloride to separate DNA molecules based on density alone. When Meselson and Stahl developed the technique in the mid-1950s, scientists had no other way to separate macromolecules that were of similar size but varied in density. Meselson and Stahl employed their method to determine how DNA replicates, became known as the Meselson-Stahl experiment. Density gradient centrifugation using cesium salts allowed scientists to isolate DNA and other macromolecules by density alone.

Mammography or mastography is an imaging technology used in the twentieth century for the detection of breast cancer and other breast abnormalities. Breast cancer is an abnormal growth in breast tissue that can spread to other parts of the body and cause death. Breast cancer affects about twelve percent of women worldwide. In the twenty-first century, mammography is one of the most accurate tools for screening and diagnosing breast cancer. A mammogram is the image created by sending low-level X-rays through breast tissue then filmed or a digital recorder captures the image, which a radiologist analyzes. A Senographe is the instrument used to create the mammogram to screen for breast cancer and other breast diseases. Mammography significantly decreased the number of deaths from breast cancer, but it can also give false positive results and cause physicians to over diagnose that may result in treatment for diseases women do not have.

Throughout history methods involving urine have been a popular way to test for pregnancy. Early ideas ranged from simply observing the color of a woman's urine to the notion that the urine of pregnant women contains special crystals or secretions. Indeed, pregnancy testing can be traced back to 1350 BCE in Ancient Egypt. A written document from the time describes a process in which a woman would urinate on wheat and barley seeds over several days and, depending on which plant grew, both the woman's pregnancy status and the sex of the fetus could be determined. In 1905, British physiologists Ernest Starling and William Bayliss were the first to isolate special hormone markers found in the urine of pregnant women.